$47.30 +0.32 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - NYSE

Sep. 16, 2014 | 04:05 PM

Partner Headlines

  1. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD | Sep. 8, 2014 | 09:07AM EST
  2. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga | Aug. 27, 2014 | 20:45PM EST
  3. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia

    Benzinga | Aug. 26, 2014 | 15:56PM EST
  4. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD | Aug. 25, 2014 | 11:40AM EST
  5. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus | Aug. 21, 2014 | 16:01PM EST
  6. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma

    Benzinga | Aug. 20, 2014 | 15:36PM EST
  7. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus | Aug. 18, 2014 | 11:54AM EST
  8. Intermune up on buyout buzz

    IBD | Aug. 13, 2014 | 18:58PM EST
  9. You Should Consider Adding GlaxoSmithKline Based on Tremendous ROE

    GuruFocus | Aug. 8, 2014 | 10:57AM EST
  10. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  11. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus | Aug. 5, 2014 | 10:51AM EST
  12. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga | Aug. 5, 2014 | 09:16AM EST
  13. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga | Aug. 4, 2014 | 12:55PM EST
  14. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus | Aug. 4, 2014 | 11:12AM EST
  15. Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab

    Benzinga | Jul. 31, 2014 | 14:30PM EST
  16. A Look at the Week's Top Dividend Growers

    GuruFocus | Jul. 28, 2014 | 19:18PM EST
  17. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga | Jul. 28, 2014 | 16:36PM EST
  18. GlaxoSmithKline

    IBD | Jul. 24, 2014 | 18:57PM EST
  19. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD | Jul. 23, 2014 | 09:00AM EST
  20. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR Yo Apotex; Apotex Can No Longer Supply Authorized Generic Product

    Benzinga | Jul. 17, 2014 | 07:02AM EST
  21. Morning Market Movers

    Benzinga | Jul. 15, 2014 | 09:46AM EST
  22. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield

    Benzinga | Jul. 11, 2014 | 04:14AM EST
  23. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus | Jul. 1, 2014 | 17:05PM EST
  24. British Stocks: Sweet Spot For European Value

    YCharts | Jun. 26, 2014 | 19:02PM EST
  25. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus | Jun. 26, 2014 | 15:40PM EST
  26. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga | Jun. 19, 2014 | 10:27AM EST
  27. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks

    Benzinga | Jun. 18, 2014 | 09:38AM EST
  28. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD | Jun. 12, 2014 | 12:57PM EST
  29. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering Efficacy, Safety of Incruse(TM) Ellipta(R) Plus Relvar(R)/Breo(R) Ellipta(R) for COPD

    Benzinga | Jun. 11, 2014 | 07:44AM EST
  30. Major British Companies Lead Top Guru-Held UK and Ireland Stocks

    GuruFocus | Jun. 10, 2014 | 19:34PM EST
  31. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga | Jun. 4, 2014 | 13:58PM EST
  32. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy

    Benzinga | Jun. 4, 2014 | 10:32AM EST
  33. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga | May. 14, 2014 | 12:36PM EST
  34. Cross-Border Megamergers Drive Global Takeover Boom

    IBD | May. 12, 2014 | 17:01PM EST
  35. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga | May. 12, 2014 | 16:27PM EST
  36. Can Pfizer Make Up Its Loss?

    GuruFocus | May. 9, 2014 | 19:24PM EST
  37. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD | May. 6, 2014 | 18:16PM EST
  38. Bayer Buys Merck Consumer Care Unit

    FoxBusiness | May. 6, 2014 | 06:22AM EST
  39. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness | May. 2, 2014 | 06:14AM EST
  40. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing GDP And Moves Forward With Taper

    Benzinga | May. 1, 2014 | 07:23AM EST
  41. Glaxo hurt by Advair scandal

    IBD | Apr. 30, 2014 | 18:50PM EST
  42. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD | Apr. 30, 2014 | 10:30AM EST
  43. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness | Apr. 30, 2014 | 07:27AM EST
  44. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness | Apr. 30, 2014 | 07:27AM EST
  45. China Rule Change Further Opens Yuan To World Markets

    IBD | Apr. 28, 2014 | 18:31PM EST
  46. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus | Apr. 28, 2014 | 13:01PM EST
  47. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine for Plasmodium Vivax Malaria

    Benzinga | Apr. 28, 2014 | 06:43AM EST
  48. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus | Apr. 27, 2014 | 23:06PM EST
  49. Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report

    Benzinga | Apr. 25, 2014 | 16:41PM EST
  50. Big Pharmas Swap Specialties

    IBD | Apr. 22, 2014 | 18:41PM EST
Trading Center